We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTA
2676
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$48 ﹤0.01%
5
MHD icon
2677
BlackRock MuniHoldings Fund
MHD
$606M
$47 ﹤0.01%
4
INDI icon
2678
indie Semiconductor
INDI
$854M
$41 ﹤0.01%
4
GDXJ icon
2679
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
$36 ﹤0.01%
1
DCTH icon
2680
Delcath Systems
DCTH
$524M
$35 ﹤0.01%
6
DEEP icon
2681
Acquirers Small and Micro Deep Value ETF
DEEP
$28.6M
$33 ﹤0.01%
1
WCLD
2682
WisdomTree Cloud Computing Fund
WCLD
$297M
$32 ﹤0.01%
1
GDX icon
2683
VanEck Gold Miners ETF
GDX
$27.4B
$30 ﹤0.01%
1
EOLS icon
2684
Evolus
EOLS
$501M
$29 ﹤0.01%
+4
New +$35
FG icon
2685
F&G Annuities & Life
FG
$3.62B
$25 ﹤0.01%
1
FREL icon
2686
Fidelity MSCI Real Estate Index ETF
FREL
$1.49B
$25 ﹤0.01%
1
BLOK icon
2687
Amplify Blockchain Technology ETF
BLOK
$1.07B
$23 ﹤0.01%
1
CRESY
2688
Cresud
CRESY
$773M
$23 ﹤0.01%
3
-158
-98% -$1.03K
APRN
2689
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$23 ﹤0.01%
4
-2
-33% -$14
IMDX
2690
Insight Molecular Diagnostics
IMDX
$156M
$20 ﹤0.01%
4
PXH icon
2691
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
$19 ﹤0.01%
1
AKO.B icon
2692
Embotelladora Andina Series B
AKO.B
$4.95B
$16 ﹤0.01%
1
FBIO icon
2693
Fortress Biotech
FBIO
$88.7M
$16 ﹤0.01%
2
GTX icon
2694
Garrett Motion
GTX
$5.57B
$15 ﹤0.01%
2
HIPO.WS
2695
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$15 ﹤0.01%
450
APPH
2696
DELISTED
AppHarvest, Inc. Common Stock
APPH
$15 ﹤0.01%
40
ETON icon
2697
Eton Pharmaceutcials
ETON
$1.22B
$14 ﹤0.01%
4
SWBI icon
2698
Smith & Wesson
SWBI
$637M
$13 ﹤0.01%
1
TNXP icon
2699
Tonix Pharmaceuticals
TNXP
$192M
0
ITCL
2700
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$4 ﹤0.01%
1

Similar funds

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.